Delivery Order 36F79720D0104-36C24524N0322
- This firm fixed price delivery order for $16,031.60 was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to United Therapeutics Corporation. The order is for TYVASO 64 MCG KIT and has a completion date of March 8, 2024. It was placed against United Therapeutics' pre-competed Pharmaceuticals and Drugs schedule contract with the General Services Administration, which has no set-aside designation. United Therapeutics will deliver the...
- This firm fixed price delivery order for $14,693.62 was awarded on March 12, 2024 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to United Therapeutics Corporation. The order procures a Tyvaso 0.6 refill kit with delivery to Bartlett, Tennessee by March 15, 2024. United Therapeutics, a manufacturer of pharmaceuticals, will provide the kit as the prime contractor under the Pharmaceuticals and Drugs Federal Supply Schedule contract....
- United Therapeutics Corporation has been awarded a $109,543.77 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The firm fixed price order has a completion date of September 30, 2023 and was awarded on March 21, 2023 to provide TYVASO, with no set-aside designation used. Place of performance will be in Bartlett, Tennessee. TYVASO will support the VA's mission...
- The U.S. Department of Veterans Affairs (VA) awarded a $31,959.14 firm fixed price delivery order to United Therapeutics Corp, a small disadvantaged business, for the provision of the Tyvaso inhalation solution. This delivery order is placed against United Therapeutics' $198 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs, which was issued by the VA in 2020. United Therapeutics also holds a $50 million Blanket Purchase Agreement (BPA) with the VA National Acquisition...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $16,391.56 order is for Tyvaso inhalation solution, one of United Therapeutics' core products used to treat pulmonary arterial hypertension. This delivery order is placed against United Therapeutics' $198 million Federal Supply Schedule (FSS) contract for...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order to United Therapeutics Corp for Tyvaso 64 mcg kit on October 29, 2025. This firm-fixed-price delivery order carries a ceiling value of $16,514.15 and is scheduled for completion by October 31, 2025. The contract will be performed in Bartlett, Tennessee. No set-aside designation was used for this award, and it represents a continuation of United Therapeutics' role as the primary...
- This firm fixed price delivery order for $16,391.56 was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to United Therapeutics Corporation on February 2, 2024. The order is for a TYVASO 0.6 REFILL KIT to be delivered to Bartlett, Tennessee by February 9, 2024. United Therapeutics is providing the refill kit as the prime contractor under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. This order was placed without a...
- The U.S. Department of Veterans Affairs (VA) awarded a $14,693.62 firm-fixed-price delivery order to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods, for the TYVASO 0.6 REFILL KIT. This delivery order is placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. United Therapeutics has two significant Indefinite Delivery Vehicles (IDVs) with the VA, including a $50 million Blanket...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to United Therapeutics Corp, a manufacturer of pharmaceutical goods. The contract, valued at $14,693.62, is for the supply of Tyvaso inhalation solution and related products to the VA's Veterans Integrated Service Network 21. United Therapeutics holds two national indefinite delivery/indefinite quantity (IDIQ) contracts with the VA, one valued at $50 million and the other at $198 million, which provide a...
- This firm fixed price delivery order contract was awarded by the Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $100,810.97 contract provides the VA's Veterans Integrated Service Network 21 with Tyvaso inhalation solution and related drugs Remodulin, Orenitram and Unituxin to treat pulmonary arterial hypertension and cancer in veterans. The order was placed against United Therapeutics'...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79720D0104Federal Supply Schedule
- 36F79720D0104-36C24524N0322Delivery Order
United Therapeutics Corporation received a firm fixed price delivery order for $16,031.60 from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The order, placed against United Therapeutics' Pharmaceuticals and Drugs schedule contract with no set-aside designation, procures Tyvaso 64 mcg kits to support the distribution of pulmonary arterial hypertension treatments to veterans. As the prime contractor, United Therapeutics will deliver the pharmaceutical products directly to VA medical facilities and clinics in Bartlett, Tennessee by the completion date of February 9, 2024. This order is associated with two larger United Therapeutics IDVs with VA totaling up to $250 million over 5-10 years, including a $50 million BPA and a $198 million task order against its Pharmaceuticals and Drugs schedule, to supply Tyvaso, Remodulin, Orenitram and Unituxin nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 2/6/24 |